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Abstract
Aspergillus fumigatus is an opportunistic fungal pathogen that infects immunocompromised patients. A putative aspartic protease
gene (ctsD; 1425 bp; intron-free) was identiWed and cloned. CtsD is evolutionarily distinct from all previously identiWed A. fumigatus
aspartic proteases. Recombinant CtsD was expressed in inclusion bodies in Escherichia coli (0.2 mg/g cells) and subjected to extensive pro-
teolysis in the baculovirus expression system. Activation studies performed on puriWed, refolded, recombinant CtsD resulted in protease
activation with a pHopt4.0 and speciWc activity D 10 U/mg. Pepstatin A also inhibited recombinant CtsD activity by up to 72% thereby
conWrming classiWcation as an aspartic protease. Native CtsD was also immunologically identiWed in culture supernatants and puriWed
from fungal cultures using pepstatin–agarose aYnity chromatography (7.8 g CtsD/g mycelia). In A. fumigatus, semi-quantitative RT-
PCR analysis revealed expression of ctsD in minimal and proteinaceous media only. Expression of ctsD was absent under nutrient-rich
conditions. Expression of ctsD was also detected, in vivo, in the Galleria mellonella virulence model following A. fumigatus infection.
© 2006 Elsevier Inc. All rights reserved.
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sive aspergillosis in immunocompromised patients [1].
Although signiWcant improvements have been forthcoming
for the identiWcation and diagnosis of A. fumigatus infec-
tion and anti-fungal therapeutic strategies, there remains a
fundamental dearth of information regarding the biology
of the organism [2]. The international collaborative eVort
directed towards the sequencing and annotation of the A.
fumigatus genome has greatly facilitated research eVorts
directed towards improving our understanding of the viru-
lence potential of the organism [3].
The degradative properties of secreted proteases have
attracted much attention as potential mediators of fungal
invasion in infected tissue, conidophore development and
iron acquisition [4,5]. For instance, the role of aspartic pro-
teases in particular has been extensively investigated in the
yeast Candida albicans and studies have shown that these
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phenotypic switching, adhesion and evasion of the host
immune response [6].
To date, a number of secreted proteases have been iden-
tiWed in A. fumigatus including a serine protease (ALP1)
[7,8], a metalloprotease (MEP)1 [9] and an aspartic protease
(PEP1) [10]. It appears that these enzymes alone may not
play a signiWcant role in the invasive characteristics of A.
fumigatus following animal studies with single alp1, mep
and pep1 mutants and double alp1 and mep mutants
[4,11,12]. However, a number of uncharacterised secretory
proteases remain within the genome, which may be capable
of compensating for the loss of these individual enzymes by
activating similar or alternative virulence pathways. C. albi-
cans employs at least 10 secreted aspartic protease (sap)
genes, and correlations between the level of proteolytic
1 Abbreviations used: MEP, metalloprotease; ABPA, allergic broncho-
pulmonary aspergillosis; MEM, minimal essential medium; FCS, fetal calf
serum.nd immunological characterisation of a secreted aspartic protease,
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deduced [6]. Essentially, the higher the level of proteolytic
activity detected, the more virulent the Candida strain. Ani-
mal studies involving sap1–3 and sap4–6 mutants demon-
strated the selective use of these proteases during mucosal
and systemic infection [13,14]. This strengthens the possibil-
ity that A. fumigatus may also be selectively using the prote-
ases at its disposal, depending on the stage and type of
infection. It is worth noting that three classes of proteolytic
enzymes have been identiWed in A. fumigatus, suggesting a
wide range of activity in diVering environmental conditions.
However, evidence of serine, metalloprotease or cysteine
protease secretion, has yet to be identiWed in any patho-
genic strains of Candida [6].
It has been suggested that the secreted aspartic protease
(PEP1) of A. fumigatus may be an allergen associated with
allergic bronchopulmonary aspergillosis (ABPA) and play
a lesser role in tissue invasion. PEP2, a cell wall associated
aspartic protease of A. fumigatus may weaken the cell wall
to allow for fungal cell growth [4]. Interestingly, another
cell wall associated serine protease (ALP2) of A. fumigatus
has been identiWed as a major allergen associated with aller-
gic asthma [15], so this may suggest that the cell wall associ-
ated proteases, such as PEP2 may play an integral role in
the development of allergic diseases. Alternatively, protease
expression may be a prerequisite for host tissue invasion,
and therefore crucial to virulence, as the regulation of these
proteases appears to exhibit signiWcant complexity, involv-
ing numerous enzymes [16,17].
In the present study, we conWrm the existence of a low-
abundance aspartic protease, CtsD, in A. fumigatus and
demonstrate the in vitro and in vivo expression patterns of
this new enzyme.
Materials and methods
Bioinformatic analysis
Preliminary sequence data were obtained from The
Institute for Genomic Research website at http://
www.tigr.org. The unannotated genome of A. fumigatus
was interrogated to identify open reading frames corre-
sponding to novel aspartic proteases. One orf was identi-
Wed, which was subsequently termed ctsD (GenBank
Accession No.: EAL90084). Sequence homologies were
determined using the BLAST algorithm (http://
www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html) and ClustalW
(http://www.ebi.ac.uk/clustalw/). The presence of signal
peptides was identiWed using the SignalP program (http://
www.cbs.dtu.dk/). The MEROPS peptidase database (http:/
/merops.sanger.ac.uk/) was used to facilitate ctsD analysis
[18].
Fungal DNA isolation and PCR ampliWcation
Aspergillus fumigatus strain ATCC 26933 was grown
(250 ml cultures) at 37 °C in minimal essential mediumPlease cite this article in press as: I. Vickers et al., Isolation, activity 
CtsD, from Aspergillus fumigatus, Protein Expr. Purif. (2007), doi:10(MEM) (containing 5% (v/v) fetal calf serum (FCS)) for 2
days. Genomic DNA was isolated as previously described
[19]. A total of 5l of genomic DNA was used in all PCRs
with 10 mM Tris–HCl, pH 9.0, 50 mM KCl, 0.1% (v/v) Tri-
ton X-100, 1.5 mM MgCl2, 200M of each dNTP, 1.0M
ctsD-forward (5-GAGAAGAGCTATGCATCTCTTAC
AATGTCTACTTTCG-3) and ctsD-reverse primer (5-G
AGACCCGGGCACCAACACCATGCAAAGAAGTG-3)
in a total volume of 49.5l. PCRs comprised an initial step
of 300 s denaturation at 95 °C, followed by 30 cycles con-
sisting of 60 s at 95 °C, 30 s at 55 °C, 90 s at 72 °C and Wnally
for 360 s at 72 °C. Amplicons were analysed by agarose gel
electrophoresis and visualised using an ‘Eagle-Eye II’ digi-
tal still video system (Stratagene, CA, USA). DNA
sequence analysis was carried out on a commercial basis
(MWG Biotech, Germany).
Cloning and expression of the aspartic protease gene, ctsD
The ctsD amplicon was cloned into pProEx™ expression
vector and baculovirus recombinants of ctsD were also gen-
erated according to the manufacturer’s instructions (Invit-
rogen). pProEx:ctsD, the expression vector containing A.
fumigatus ctsD, was transformed into Escherichia coli
according to the manufacturer’s guidelines (Invitrogen).
Protein expression was induced by the addition of isopro-
pyl--D-thiogalactopyranoside (IPTG; 0.6 mM Wnal con-
centration) and monitored by SDS–PAGE, Western blot
analysis (His6 fusion tag) and MALDI-TOF mass spec-
trometry [19].
Recombinant CtsD puriWcation, activity and immunological 
analysis
Recombinant CtsD was puriWed under denaturing con-
ditions using Ni–NTA metal–chelate aYnity chromatogra-
phy in the presence of 6 M guanidine–HCl [20]. PuriWed
recombinant CtsD (250g/ml) in 50 mM sodium carbonate,
pH 9.4, containing 6 M guanidine–HCl was serially dialysed
into 50 mM sodium carbonate, pH 9.4, containing 8 M urea,
then 4 M urea, followed by dialysis into 50 mM sodium car-
bonate buVer, pH 9.4, to facilitate solubilisation. Protease
activity was quantiWed using bovine hemoglobin as sub-
strate using a modiWed protocol (2 h incubation) to that
previously described [21]. One unit of activity was deWned
as A280nm D 0.1 observed after a two hour incubation at
37 °C (pH 4.0). Pepstatin inhibition studies were carried out
as previously described [22]. Rabbit immunisation (n D 5
occasions) was performed over a period of 4 months using
puriWed recombinant CtsD (50g per immunisation) as
antigen source. Rabbit CtsD antibody was puriWed by Pro-
tein-A–Sepharose™ aYnity chromatography (Amersham
Biosciences). Pre-immune rabbit antisera was also puriWed
in this manner. Western blot detection of both native and
recombinant CtsD was performed using immune antisera
(1/2000) and goat anti-rabbit IgG–horseradish peroxidase
conjugate (1/1000–1/15000) using either diaminobenzidineand immunological characterisation of a secreted aspartic protease,
.1016/j.pep.2006.12.012
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detection (Pierce Biotechnology).
Native CtsD protein analysis and puriWcation
Aspergillus fumigatus culture supernatants (24–96 h;
MEM and MEM + 5% (v/v) FCS) were collected and sub-
jected to immunological analysis using CtsD antisera. CtsD
was puriWed from MEM culture supernatants (72 h; 250 ml)
on pepstatin–agarose aYnity resin (Pierce Biotechnology).
The column (5 ml) was washed to remove unbound pro-
teins using phosphate-buVered saline (PBS) and fractions
(0.5 ml) were eluted using 20 mM Tris containing 450 mM
NaCl, pH 7.9. Enzyme activity was determined as described
above.
CtsD-speciWc competitive ELISA
The presence of CtsD in both MEM and MEM + 5%
(v/v) FCS culture supernatants was determined by com-
petitive ELISA. Relevant A. fumigatus culture superna-
tants were pre-incubated at room temperature for 30 min
at 200 rpm with CtsD antisera (1/1000 dilution). Speci-
mens (100 l each) were loaded, in duplicate, onto 96-well
microtitre plates pre-coated with recombinant CtsD anti-
gen (0.2 g/well) and incubated for 1 h at room tempera-
ture. Plates were washed twice with PBS–0.05% (v/v)
Tween 20, protein A–horseradish peroxidase conjugate
(100 l/well) added and incubated for 1 h at room temper-
ature. After washing, tetramethylbenzidine substrate
(100 l/well) was added incubated for 10 min and the reac-
tion was stopped by the addition of 100 l of 1 N sulphu-
ric acid per well. The absorbance was determined at
450 nm/630 nm and the concentration of CtsD in media
supernatants was determined from a standard curve of 0–
10 g/ml recombinant CtsD.
ctsD gene expression in culture
Aspergillus fumigatus conidia were inoculated into (i)
Sabouraud media, (ii) 5% (v/v) FCS in MEM, (iii) 10% (v/v)
FCS in MEM, and (iv) 20% (v/v) FCS in MEM, respec-
tively. Cultures were harvested at deWned time-points (24,
48, 72 and 96 h) and total A. fumigatus RNA was isolated
using a TRI® reagent method (Sigma–Aldrich) and DNase
I-treated. Equivalent amounts (0.5g) of RNA were used to
generate cDNA at each time point, in addition to carrying
out parallel control RT-PCR using calm primers as the
housekeeping gene [23]. cDNA was synthesised according
to standard procedures (Invitrogen) and 1l of each cDNA
sample was introduced into PCR reactions as described
above using PCR primers: forward (5-GAGAAGGCCT
TCAAATGGTGTCTCTTTAACGTTGG-3) and reverse
(5-GAGAGGTACCCACCAACACCATGCAAAGAA
GTG-3). As calm DNA contains introns, a larger amplicon was
expected for the genomic DNA relative to the cDNA amplicon.Please cite this article in press as: I. Vickers et al., Isolation, activity a
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Experimental approaches were developed (i) to deter-
mine if ctsD was expressed during infection and (ii) to
assess the functional role of CtsD, using the Galleria
mellonella insect model [24]. First, G. mellonella larvae (n
D 200) were inoculated into the hind pro-leg with 5 £ 105
A. fumigatus conidia in 20 l (per larva) followed by total
RNA extraction at 0, 24, 48, 72 and 96 h time-points (50
larvae/RNA extraction). ctsD gene expression was
assessed using RT-PCR as described above. Second, G.
mellonella larvae (n D 20 per group) were inoculated as
above with either (i) A. fumigatus conidia (107 per lar-
vae), (ii) co-inoculated with 20 g (2 g/l) of rabbit anti-
CtsD IgG and 107 A. fumigatus conidia, (iii) pre-immune
rabbit IgG (20 g (2 g/l)) with 107 conidia or (iv) PBS-
only inoculation (negative control). The survival rate of
the G. mellonella larvae was determined at 72 h. Statisti-
cal analysis was carried out using the ANOVA one-way
analysis of variance test.
Results and discussion
Phylogenetic analysis of CtsD and related aspartic proteases
Using a bioinformatic approach, a unique aspartic
protease (CtsD), demonstrating signiWcant identity (58%)
to an unnamed protein product of Aspergillus oryzae
(GenBank Accession No.: BAE59370), 52% identity to an
A. nidulans hypothetical protein and 48% identity
to aspartyl protease 4 (PEP4) of Coccidioides posadasii,
was identiWed following BLAST analysis of the unanno-
tated A. fumigatus genome. CtsD was also classiWed as a
subfamily A1A aspartic protease following MEROPS
analysis [18]. CtsD formed no grouping with any
other characterised or putative aspartic protease of A.
fumigatus (at least seven in total; data not shown). More-
over, amino acid sequence identity of 30% was observed
with only one putative cellular aspartic protease in
A. fumigatus (GenBank Accession No.: XP_754479).
CtsD exhibited 28% and 29% identity to A. fumigatus
PEP1 [10] and PEP2 [4], respectively. CtsD exhibited 24%
identity to a previously unidentiWed putative aspartic
protease (OpsB; [3] in this organism. An OpsB homo-
logue is also present in A. oryzae. Identity (32%) was
also shared between CtsD and preprocathepsin D of
Dictyostelium discoideum [25]. Phylogenetic analysis
of CtsD with aspartic proteases of Aspergillus niger
(PEPE; [26]) and C. albicans (SAP2 and SAP6) demon-
strated that these proteases are unlikely to be sister
taxa of CtsD (Fig. 1). A 19 amino acid signal peptide
was also identiWed using the SignalP program, suggesting
a secretory pathway for CtsD production, however, no
propeptide cleavage site was predicted. A conserved
aspartic protease DTG-motif was present in the active
site of all analysed sequences (data not shown).nd immunological characterisation of a secreted aspartic protease,
.1016/j.pep.2006.12.012
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Following PCR optimisation, the entire open reading
frame of ctsD was isolated, yielding a product of 1425 bp.
Following DNA sequence analysis it was subsequently
inserted into a pProEx expression vector. Protein expres-
sion plasmid pProEx:ctsD, consisting of the vector pProEx-
Htb™ containing the entire open reading frame of ctsD
was transformed into E. coli XL1-Blue and expression
induced at 0.6 mM IPTG (Fig. 2a). The resultant recombi-
nant protein (58 kDa) was highly insoluble and present in
the cell pellet as determined by SDS–PAGE and Western
blot analysis using monoclonal antibody reactivity against
Fig. 1. Phylogenetic relationship between A. fumigatus CtsD and selected
fungal aspartic proteases (actual and putative). CtsD is most closely
related to putative aspartic proteases from related fungal species but dis-
tinct from previously identiWed enzymes (PEP1 and 2) in A. fumigatus.
Aspartic proteases: CtsD (GenBank Accession No. (GAN): EAL90084),
A. oryzae (putative) (PAPory; GAN: BAE59370), A. nidulans (putative)
(PAPnid; GAN: AN4422.2), C. posadasii PEP4 (GAN: ABA54909), A.
fumigatus (putative) (PAP1fum; GAN: EAL86405), A. niger (PEPE;
GAN: AAA0876), A. fumigatus PEP2 (GAN: CAA75754), C. albicans
(SAP2 and SAP6; GAN: XP_711047 and Z30192, respectively), A. oryzae
(putative) (OpsBory; GAN: BAC00848), A. fumigatus (putative) (OpsB;
GAN: XM_742449), A. fumigatus PEP1 (GAN: EAL91286), A. fumigatus
(putative) (PAP2fum; GAN: EAL93892) and A. fumigatus (putative)
(AP1fum; GAN: EAL85712).Please cite this article in press as: I. Vickers et al., Isolation, activity 
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binant CtsD was puriWed using diVerential extraction and
Ni–NTA metal–chelate aYnity chromatography, with a
yield of approximately 0.2 mg/g of E. coli and to a purity
greater than 95% as judged by SDS–PAGE and Western
analysis (Fig. 2c and d). Peptides (following tryptic diges-
tion of CtsD) were identiWed by MALDI-TOF mass spec-
trometry [19] which corresponded to the theoretical amino
acid sequence of CtsD whereby 7/42 peptides (22%
sequence coverage) was observed. Recombinant PEP2 has
been successfully expressed in, and secreted from, the yeast
Pichia pastoris [21].
Immunological and activity analysis of recombinant CtsD
The antisera generated against recombinant CtsD was
highly reactive (detection limit: 12ng recombinant CtsD) and
distinct bands were visible following Western blot analysis
(Fig. 2e). The observed immunogenicity of CtsD is not unex-
pected. Indeed, an allergenic role for fungal proteases has been
previously proposed for a number of proteases PEP1 [10],
ALP2 [15] and it is thought that they may play an important
role in conditions such as allergic asthma or ABPA. In an
attempt to express soluble and functional CtsD in a eukary-
otic system for activity analysis, expression of CtsD was also
undertaken using the baculovirus expression system in Spo-
doptera frugiperda (Sf9) insect cells. The antisera raised against
the E. coli-expressed recombinant CtsD was used to detect
CtsD expression. Although intracellularly located recombi-
nant CtsD was evident at diVerent molecular masses (30–
60kDa; (Fig. 2f and g)) and 80kDa (not shown), possibly due
to glycosylation or proteolytic processing, protein insolubility
was again observed. At least 6 N-glycosylation sites were pre-
dicted using NetNGlyc 1.0 (http://www.cbs.dtu.dk), with the
highest support for an N-glycosylation site at amino acid
positions 301 and 304. Only one O-glycosylation site at posi-
tion 421 of the native protein was predicted using the DictyO-
Glyc 1.1 program. Baculovirus-expressed recombinant CtsD
was not secreted (data not shown).
Consequently, activity and inhibitor analysis was carried
out on refolded, E. coli-expressed, CtsD which obviated the
requirement to express the protein in an alternative expres-
sion system (e.g., A. oryzae or Pichia pastoris). It can be seen
from Fig. 3a that optimal CtsD enzyme activity was evident
at pH 4.0 and was 2.5 times greater than that observed at
pH 3.0 as determined by the hemoglobin proteolysis assay
(using 5g recombinant CtsD per assay). Moreover, the
speciWc activity of recombinant CtsD was 10 U/mg under
optimal assay conditions (pH 4.0). The narrow pH range
over which activity was evident contrasts markedly with the
wide activity range (pH 2–7), with pHopt at 2.5–3.0,
observed for PEP2 from A. fumigatus [21]. Furthermore,
the localisation of PEP2 to the cell wall fraction and
absence from culture supernatants indicates that both
PEP2 and CtsD play distinct roles in A. fumigatus. Recom-
binant CtsD activity was inhibited by up to 72% in the pres-
ence of 14M Pepstatin A (Fig. 3b). The observation ofand immunological characterisation of a secreted aspartic protease,
.1016/j.pep.2006.12.012
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protease as has been previously demonstrated for both
PEP1 and PEP2, although complete activity inhibition was
observed for PEP1 and PEP2 [4,21]. This diVerence may be
related to the distinct evolutionary nature of CtsD versus
PEP1/PEP2 (Fig. 1).
Reichard et al. [27] have also reported the identiWcation
of four secreted proteases (Sedolisin A–D) from A. fumiga-
tus which are distinct acidic proteases relative to CtsD. Sed-
olisin A, an endoprotease, exhibits a pHoptimum  5.5 (pHPlease cite this article in press as: I. Vickers et al., Isolation, activity a
CtsD, from Aspergillus fumigatus, Protein Expr. Purif. (2007), doi:10range 3.0–6.5), while Sedolisin B–D (pHoptima (pH range):
6.0 (3.0–7.0), 6.0 (3.0–7.0) and 5.0 (1.5– 6.0), respectively)
exhibit tripeptidyl peptidase activity only.
Immunological and activity analysis of native CtsD
Analysis of A. fumigatus native proteins following pep-
statin–agarose aYnity chromatography of MEM culture
supernatants (72 h) demonstrated the presence of a protein
of identical molecular mass to recombinant CtsD, in addi-Fig. 2. SDS–PAGE and Western blot analysis of CtsD expressed in E. coli and the baculovirus expression system. (A) Coomassie stained SDS–PAGE gel
of induced E. coli expressing CtsD. (B) Western blot of recombinant E. coli expressing CtsD. The Western blot was probed with 1/500 dilution of anti-His6
monoclonal antibody, 1/1000 dilution of anti-mouse IgG–horseradish peroxidase. (Lane M) Protein molecular mass marker. (Lane 1) Untransformed XL-
1 Blue E. coli. (Lane 2) Uninduced XL-1 Blue E. coli. (Lanes 3–5) XL-1 Blue E. coli, 1, 2 and 3 h post-induction with IPTG, respectively. A band represen-
tative of recombinant CtsD is present in each of these tracks. SDS–PAGE (C) and Western blot (D) of puriWed recombinant CtsD following diVerential
extraction and Ni–NTA metal–chelate aYnity chromatography. Western blot of puriWed batches probed with 1/500 dilution of monoclonal anti- His6, 1/
1000 dilution of goat anti-mouse IgG-HRP, and diaminobenzidine/H2O2 substrate system. (Lane M) Protein marker. (Lane L) E. coli cell lysate contain-
ing recombinant CtsD. (Lanes 1–2) PuriWed CtsD—Batches 1 and 2, respectively. (E) Western blot analysis of rabbit polyclonal anti-CtsD sera reactivity
against recombinant CtsD. Recombinant CtsD (1.5 g/track) was probed (1/100 dilution) with respective antisera and 1/1000 dilution of protein A–horse-
radish peroxidase conjugate. (Lane PI) Rabbit pre-immune sera. (Lanes 1 and 2) Rabbit anti-CtsD sera bleed 1 and Wnal bleed, respectively. Immunoreac-
tive CtsD fragments (p30) of lower molecular mass (30 kDa) are also visible. SDS–PAGE (F) and Western blot analysis (G) of CtsD recombinant
baculovirus clones (recombinants 1–4). (Lane M) Protein marker. (Lane P) E. coli-expressed CtsD (0.1 g). (Lane N) Sf9 insect cells only. (Lanes 1–4)
CtsD recombinants 1–4, respectively. Western blots were probed with a 1/200 dilution of anti-CtsD IgG, followed by a 1/1000 dilution of goat anti-rabbit
IgG–horseradish peroxidase conjugate/diaminobenzidine. Recombinants 1 and 2 demonstrated a similar expression pattern, with expression detected at
58 kDa. The lower band of approximately 45 kDa may have been a mature and processed form of CtsD. Recombinant 4 was evident at 35 kDa, and may
represent a truncated form of CtsD.nd immunological characterisation of a secreted aspartic protease,
.1016/j.pep.2006.12.012
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reactivity was also evident at a molecular mass coincident
with that of recombinant CtsD which conWrms that native
CtsD is secreted by A. fumigatus (Fig. 4b). The lower
molecular mass protein, p40, was also detected using anti-
CtsD antibody (Fig. 4b) and may represent a degradation
product or a proteolytically processed, active form of CtsD.
In addition, aspartic protease activity (28 U) was also
detected in these column fractions. Using a CtsD competi-
tive ELISA, CtsD (3.65g/ml) was detected in acetone-pre-
cipitated 72 h MEM supernatants, which was signiWcantly
higher then enzyme levels observed at any other time-point.
CtsD levels of approximately 3g/ml were also detected in
96 h MEM + 5% (v/v) FCS culture supernatants. These
observations suggest that CtsD is secreted from A. fumiga-
tus as a zymogen. Similarly, human procathepsin D
(52 kDa) is proteolytically processed to a 48 kDa protein
Fig. 3. (a) Activity analysis of activated recombinant CtsD. Optimal activ-
ity was obtained at pH 4.0 according to the hemoglobin assay. No activity
was detected at either pH 2.0 or 5.0. All assays were performed in dupli-
cate and data are presented as means § SE. (b) Inhibition of recombinant
CtsD activity with Pepstatin A. Column 1 represents the activity detected
for recombinant CtsD alone and column 2 represents the activity detected
following incubation of the aspartic protease inhibitor Pepstatin A
(0.014 M), using hemoglobin as substrate. All assays were performed in
duplicate. Recombinant CtsD activity was inhibited (72%) in the presence
of Pepstatin A.
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fact that the zymogen form of native CtsD was evident
after puriWcation may be due to the pH employed for aYn-
ity chromatography.
The extent and pattern of protein secretion by A. fumig-
atus (strain ATCC 46645) has been demonstrated to be
dependent on the media used for fungal culture, although it
is possible that selective concentration of culture superna-
tants is necessary for optimal secreted protein detection
[29]. These authors used direct N-terminal sequence and
MALDI-TOF mass spectrometry analysis to determine the
presence of 5 proteins (mitogillin, PEP1, chitosanase
(CsnB), chitinase (ChiB1) and a (1–3) endoglucanase) in
A. fumigatus culture supernatants, primarily in Aspergillus
minimal media (AMM). Schwienbacher et al. [29] noted
that no signiWcant protein secretion was detectable after
growth in Hepes-buVered RPMI 1640 cell culture medium.
Thus, the aYnity chromatographic approach adopted to
purify native CtsD from A. fumigatus MEM culture super-
natants may therefore be essential to identify low-abun-
dance secreted proteins from A. fumigatus.
DiVerential expression of ctsD under alternative culture 
conditions
Total RNA was extracted from A. fumigatus grown
under diVerential culture conditions, purity assessed, and
quantitation achieved, by UV spectrophotometry and
rRNA visualisation (Fig. 5a). Control RT-PCR analysis
using calm primers conWrmed the absence of genomic DNA
as determined by the smaller amplicon size of the calm
cDNA amplicon relative to the corresponding genomic
amplicon (data not shown) [23]. ctsD does not contain
introns as the same amplicon size was obtained for ampli-
cons representative of cDNA and genomic DNA. Expres-
sion of ctsD is not constitutive and is dependent on the
Fig. 4. SDS–PAGE and Western blot analysis of native CtsD from puri-
Wed from A. fumigatus culture supernatant (72 h post-inoculation) follow-
ing pepstatin–agarose aYnity chromatography. (a) Coomassie blue
stained SDS–PAGE analysis of puriWed fractions. (Lane M) Protein
marker. (Lane P) Recombinant CtsD from E. coli. (Lanes 1–6) Column
fractions 1–6, respectively. (b) Western blot analysis of puriWed fractions.
The Western blot was probed with a 1/200 dilution of anti-CtsD sera, 1/
1000 dilution of protein A–horseradish peroxidase conjugate and an
enhanced chemiluminescent (ECL) substrate detection system was
employed. (Lane M) Protein marker. (Lanes 1–8: Column fractions 1–6,
respectively. (Lane P) Recombinant CtsD from E. coli. Protein p40 was
evident in fraction 3 following pepstatin–agarose chromatography.and immunological characterisation of a secreted aspartic protease,
.1016/j.pep.2006.12.012
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ARTICLE IN PRESSgrowth medium used for fungal culture. In buVered cul-
tures, expression of ctsD by RT-PCR, was evident at 72 and
96 h only following culture of A. fumigatus in MEM
medium alone (Fig. 5b). Further analysis of ctsD expression
revealed constitutive expression at 24, 48, 72 and 96 h in
proteinaceous media (i.e., MEM containing 5%, 10% and
20% (v/v) FCS, respectively) (Fig. 5c–e) but not in nutrient
rich, non-proteinaceous, Sabouraud media at any time
point (Fig. 5f) and is suggestive of a role for CtsD in the
release of iron from iron-binding proteins.
Interestingly, GiVord et al. [5] have shown that induction
of protease secretion occurs in A. fumigatus cultured in the
presence of human or fetal bovine serum (FBS) and that it
may, in part, contribute to the release of iron from iron-
binding proteins by proteolysis. These authors noted that
iron levels were undetectable in MEM and that FBS con-
tained 20M iron (equivalent to 1–4M iron in 5–20% (v/
Fig. 5. Expression analysis of ctsD expression between 24 and 96 h under
various culture conditions. (a) Quantitation of intact RNA from A. fumig-
atus: (1–4) MEM only, (5–8) MEM + 5% (v/v) FCS, (9–12) MEM + 10%
(v/v) FCS, (13–16) MEM + 20% (v/v) FCS and (17–20) Sabouraud media,
respectively. (b–f) RT-PCR analysis of ctsD expression between 24 and
96 h under various culture conditions. (b) Lanes 1–4: ctsD cDNA gener-
ated from A. fumigatus 24, 48, 72 and 96 h following culture in MEM only,
(c) MEM + 5% (v/v) FCS, (d) MEM + 10% (v/v) FCS, (e) MEM + 20% (v/
v) FCS and (f) Sabouraud media, respectively. (Lane P) ctsD genomic
DNA. (Lane N) Negative control. (Lane M) DNA marker. Expression of
ctsD is apparent at 72 and 96 h culture time-points in MEM alone and at
all time-points when FCS was present. No ctsD expression detected in A.
fumigatus cultured in Sabouraud media over a 24–96 h time period.Please cite this article in press as: I. Vickers et al., Isolation, activity a
CtsD, from Aspergillus fumigatus, Protein Expr. Purif. (2007), doi:10v) FCS). Expression of ctsD was absent in Sabouraud
media which only contains 5 nM iron (data not shown),
thus it seems unlikely that CtsD plays a role in iron acquisi-
tion in the absence of iron-binding proteins such as trans-
ferrin. It is notable that the assay conditions employed by
GiVord et al. to assess protease activity (pH 7.5) would have
precluded detection of aspartic protease contribution to
serum protein hydrolysis [5]. Consequently, the RT-PCR
data presented herein, combined with the detection of CtsD
by ELISA, additionally demonstrate that aspartic protease
activity is also induced in the presence of serum proteins.
Thus, we suggest that future studies, on the elucidation of
serum factors which may induce protease secretion by A.
fumigatus, should include determination of protease activ-
ity over a wide pH range.
Expression of ctsD in A. fumigatus-infected G. mellonella
Precise quantitation of total RNA (larval and fungal)
used for cDNA synthesis was undertaken (data not shown).
Furthermore, the presence of genomic ctsD was eliminated
by the use of DNase I and conWrmed by the ampliWcation
of calm cDNA ([23] 348 bp; Fig. 6a). G. mellonella calm
cDNA is identical in size to that from A. fumigatus and so
is apparent in uninfected Galleria. It can be seen from
Fig. 6b that ctsD expression was evident at 24, 48, 72 and
96 h post-inoculation of G. mellonella with A. fumigatus
conidia. Moreover, amplicons were subjected to DNA
sequence analysis which conWrmed they were of fungal ori-
gin (data not shown). There was an apparent increase in
ctsD expression between 24 and 96 h (Fig. 6b) and a similar
pattern of expression was observed for opsB (Fig. 1),
although a higher level of expression was evident relative to
Fig. 6. Infection model studies. (a) RT-PCR analysis of calm control
expression [23] in a Galleria mellonella virulence model. (Lane 1) Unin-
fected Galleria. (Lanes 2–5) 24, 48, 72 and 96 h post-infection with A.
fumigatus conidia (2 £ 105). (Lane P) calm genomic DNA. (Lane N) Nega-
tive control. (b) Expression analysis of ctsD. (Lanes 2–5) ctsD expression
in infected Galleria, 24, 48, 72 and 96 h post-infection with A. fumigatus
conidia, respectively. (Lane P) ctsD genomic DNA. (Lane N) Negative
control. (c) Expression analysis of opsB (Fig. 1). (Lanes 2–5) opsB expres-
sion in infected Galleria, 24, 48, 72 and 96 h post-infection with A. fumiga-
tus conidia, respectively. (Lane P) opsB genomic DNA. (Lane N) Negative
control.nd immunological characterisation of a secreted aspartic protease,
.1016/j.pep.2006.12.012
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ARTICLE IN PRESSctsD (Fig. 6c). While it cannot be entirely excluded that the
observed increase in ctsD and obsB expression, respectively,
was due to the larger fungal mass present in the larval
material, the consistency of calm cDNA strongly suggests
that increased aspartic protease gene expression had
occurred. Relevantly, da Silva Ferreira et al. [30] have also
detected signiWcantly increased opsB expression in A.
fumigatus mycelia as part of microarray studies of alter-
ation in global gene expression following exposure to the
antifungal drug, voriconazole. Thus, we hypothesise opsB
expression occurs in response to either host- or drug-
induced stress in A. fumigatus and merits future study.
A statistically signiWcant improvement in the survival
rate of the Galleria was observed at 72 h (p D 0.0004), fol-
lowing the co-administration of anti-CtsD IgG and A.
fumigatus conidia, relative to the administration of A.
fumigatus conidia alone or conidia with pre-immune IgG
(Fig. 7). This observation further conWrms that CtsD
expression occurs in A. fumigatus-infected G. mellonella. To
our knowledge, one other secreted aspartic protease of A.
fumigatus has been previously characterised, namely, PEP1
[10] whereas PEP2 has been shown to be associated with
the fungal cell wall. Mutants lacking PEP1 showed no alter-
ation in the virulence potential of the fungus. The in vivo
virulence potential of other proteases such as MEP and
ALP have also been investigated [11,12], with results indi-
cating that no signiWcant diVerence in virulence was
obtained with mutants lacking these proteases. Thus, our
data may represent the Wrst identiWcation of an A. fumiga-
tus encoded aspartic protease (CtsD) associated with the
fungal virulence, although direct proof will require the gen-
eration of a ctsD mutant followed by comparison with A.
fumigatus wild-type pathogenicity. The use of G. mellonella
to assess fungal virulence is attracting ever-increasing
attention. Small and Bidochka [31] have evaluated the pat-
tern of Metarhizium anisophilae pr1 gene expression in G.
mellonella and others [32] have ascertained the virulence
attenuation of methylcitrate synthetase mutants of A.
fumigatus. The Galleria model system has also been used to
Fig. 7. Determination of virulence potential of CtsD in Galleria mellonella
insect model. A statistically signiWcant (p D 0.0004) improvement in the
survival rate of G. mellonella co-inoculated with anti-CtsD IgG (20 g)
and A. fumigatus conidia (107) at 72 h was observed, relative to co-inocu-
lation with either pre- immune IgG and A. fumigatus conidia (107), PBS or
A. fumigatus conidia (107).
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[33]. However, the use of antibody administration to dimin-
ish the eVects of potential virulence factors has not been
previously reported and oVers an alternative approach for
the use of the G. mellonella system in virulence assessment
studies.
In conclusion, a novel aspartic protease, CtsD, has
been identiWed and characterised from the pathogenic
fungus, Aspergillus fumigatus. CtsD expression was
repressed under nutrient-rich culture conditions. Expres-
sion of ctsD was detected in Galleria mellonella insect lar-
vae inoculated with A. fumigatus and anti-CtsD IgG
exhibited a statistically signiWcant protective eVect against
fungal infection in the insect model system. These data
represent the Wrst identiWcation of this novel aspartic pro-
tease and suggest possible functions for the enzyme in A.
fumigatus.
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